Issuers compared with Closir

Closir alternative for investor targeting and IR CRM

Issuers is a Closir alternative for US listed small and mid caps that want investor targeting, an investor CRM, an IR website and disclosure approvals in one workspace. Growth starts at $499 a month billed yearly. Public includes the IR website at $1,499 a month billed yearly. Closir pricing comes from a sales quote.

An investor targeting shortlist and meeting notes on a desk

01 Direct answer

Buy-side engagement tool or one IR workspace

Closir, a London based investor relations platform, fits issuers that want a dedicated tool to understand and approach the buy-side. Issuers fits a US small or mid cap that wants targeting from SEC filings plus the investor CRM, IR website and disclosure approvals in the same subscription. Issuers starts at $499 a month billed yearly and the website sits on Public at $1,499. Closir needs a quote, so any saving depends on your proposal.

02 Comparison

Closir and Issuers side by side

Descriptions of Closir come from public directory listings. Where a capability is not described there, treat it as a question for the vendor rather than a claim about everything Closir sells.

Comparison of Issuers and Closir
Topic	Closir	Issuers
Who they are	London based online investor relations platform, described in company directories as helping issuers understand the buy-side.	Self-service IR software built for US issuer filings and IR workflows.
Investor targeting	Core of the pitch: buy-side intelligence and outreach planning. Confirm data sources and regions in your demo.	Investor targeting from 13F, 13D and 13G filings with fit scores and one page fund briefs.
Investor CRM	Engagement tracking for investor meetings. Confirm depth with the vendor.	Contacts, funds, interaction history, notes and meeting briefs in the same workspace.
IR website	Not described as a core product. Ask for the current scope.	Hosted IR website on your subdomain with Public.
Disclosure approvals	Not described as a product. Ask the vendor.	Approvals with an audit trail retained for 7 years on Public and Enterprise.
US filing data	Coverage of US ownership filings should be confirmed against your own ticker.	Built around SEC filings of US issuers.
Pricing	Not published in the sources we reviewed. Quote through a sales conversation.	Growth $499, Public $1,499 and Enterprise $3,999 a month billed yearly.
Buying process	Demo and contract.	Self-service checkout. No sales call.
Best for	Issuers, often outside the US, that want a dedicated buy-side engagement tool with vendor support.	US small and mid caps that want targeting, CRM, website and approvals at a listed price.

For a wider shortlist, see the investor targeting software page, the investor relations CRM and the ingage alternative page.

Closir is a name of its respective owner, used only to identify the product compared. Descriptions reflect public information at the time of writing. Confirm current scope and terms in your proposal.

03 Closir strengths

When Closir is the better buy

A dedicated buy-side tool

If your investor base sits mostly outside the US and buy-side engagement is the whole job, a specialist platform with vendor support may fit better. Issuers is built around US SEC filings.

Vendor support and onboarding

A team that wants a vendor to help plan outreach and coach the first meetings may value a managed relationship. Issuers is self-service and expects your IR lead to drive it.

Non-US coverage

Issuers does not cover non-US ownership registers. A company with a large European or UK holder base should check coverage in any tool it picks.

04 Issuers strengths

When Issuers is the better buy

A known price

Plans are listed on the pricing page and bought through checkout. Public at $1,499 a month billed yearly is $17,988 a year, with the website, CRM, ownership data and approvals included.

Your team publishes

News, results, presentations and governance pages are updated by your staff in the IR website module, without change requests to an agency. Counsel and the CFO still approve what goes live.

Approvals and CRM behind the site

The disclosure approval workflow keeps decisions with an audit trail, and the investor relations CRM holds contacts and meeting history in the same workspace.

05 Cost worksheet

Build the renewal worksheet from your quote

Ask Closir for the annual fee, the number of users, data coverage by region and any charge for extra contacts or reports. These are questions for your quote, not a claim that Closir charges for each item.

Record the contract term, renewal notice and your export rights for contacts and meeting notes. Then add what you pay today for a separate IR website, approvals and CRM, since those sit in one Issuers plan.

For a US issuer that wants the website, ownership data and approvals, use Public as the comparison: 25,000 contacts, 120 briefs a month, 10 seats and a 7 year audit log.

Subscription inputs for your worksheet

Closir annual platform fee: your written quote
Closir users, data and renewal: confirm with Closir
Growth, billed yearly: $499 a month
Public, billed yearly: $17,988 a year
Public, month to month: $2,999 a month
Enterprise, billed yearly: $3,999 a month

06 Move plan

Move your investor data without losing history

Step 1

Export your data

Request contacts, fund lists, meeting notes and interaction history as CSV, and confirm your export rights before you give notice.
Step 2

Import to the CRM

Load contacts and notes into the investor relations CRM and build target lists from 13F, 13D and 13G ownership of your own ticker.
Step 3

Log the next meetings

Use one page briefs for each fund meeting and record outcomes so the history is complete from the first quarter.
Step 4

End the old contract

Once a full quarter of meetings is logged in Issuers, end the old contract according to its notice terms.

Questions

Closir alternative questions from CFOs and IR leads

What is a good alternative to Closir?

Issuers is a good Closir alternative for a US listed small or mid cap that wants investor targeting from SEC filings, an investor CRM, an IR website and disclosure approvals in one subscription. Growth starts at $499 a month billed yearly. Keep Closir if you need its buy-side engagement tooling for a non-US investor base.

How much does Closir cost?

We found no published Closir price in the sources we reviewed, so treat it as a quote. Ask for the annual fee, the number of users, data coverage and renewal terms in writing. Issuers publishes Growth at $499, Public at $1,499 and Enterprise at $3,999 a month billed yearly.

Who are the main Closir competitors?

Directories list ingage, Irwin, Q4 and Navatar among Closir competitors, plus advisory firms. They split into IR CRM and corporate access tools, targeting and monitoring tools, and full IR suites, so match each one to the work your team will own.

Can we move our investor data from Closir to another platform?

Ask Closir for an export of your contacts, meeting notes and interaction history in CSV, then import the contacts into the Issuers investor CRM. Keep the old tool running until the first quarter of meetings is logged in the new one so nothing is lost.

Does Issuers cover investor targeting like Closir?

Yes for US filings. Issuers builds target lists from 13F, 13D and 13G ownership, scores fit and writes a one page brief per fund. It does not replace a bank or broker corporate access desk, and it does not run roadshow scheduling with outside investors.

Price a Closir alternative with your own ticker

Read a sample investor brief from public SEC filings. Review the published plans and start through self-service checkout. Growth starts at $499 a month billed yearly. Public adds the IR website and disclosure approvals at $1,499 a month billed yearly.

Compare plans